1. Home
  2. FEIM vs HUMA Comparison

FEIM vs HUMA Comparison

Compare FEIM & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEIM
  • HUMA
  • Stock Information
  • Founded
  • FEIM 1961
  • HUMA 2004
  • Country
  • FEIM United States
  • HUMA United States
  • Employees
  • FEIM N/A
  • HUMA N/A
  • Industry
  • FEIM Electrical Products
  • HUMA Biotechnology: Pharmaceutical Preparations
  • Sector
  • FEIM Industrials
  • HUMA Health Care
  • Exchange
  • FEIM Nasdaq
  • HUMA Nasdaq
  • Market Cap
  • FEIM 291.0M
  • HUMA 250.2M
  • IPO Year
  • FEIM N/A
  • HUMA N/A
  • Fundamental
  • Price
  • FEIM $32.25
  • HUMA $1.51
  • Analyst Decision
  • FEIM
  • HUMA Strong Buy
  • Analyst Count
  • FEIM 0
  • HUMA 8
  • Target Price
  • FEIM N/A
  • HUMA $10.88
  • AVG Volume (30 Days)
  • FEIM 278.1K
  • HUMA 5.9M
  • Earning Date
  • FEIM 09-12-2025
  • HUMA 08-11-2025
  • Dividend Yield
  • FEIM N/A
  • HUMA N/A
  • EPS Growth
  • FEIM 316.95
  • HUMA N/A
  • EPS
  • FEIM 2.46
  • HUMA N/A
  • Revenue
  • FEIM $69,811,000.00
  • HUMA $818,000.00
  • Revenue This Year
  • FEIM $12.60
  • HUMA N/A
  • Revenue Next Year
  • FEIM $19.17
  • HUMA $949.92
  • P/E Ratio
  • FEIM $13.11
  • HUMA N/A
  • Revenue Growth
  • FEIM 26.30
  • HUMA N/A
  • 52 Week Low
  • FEIM $11.71
  • HUMA $1.15
  • 52 Week High
  • FEIM $33.72
  • HUMA $6.77
  • Technical
  • Relative Strength Index (RSI)
  • FEIM 63.44
  • HUMA 36.87
  • Support Level
  • FEIM $25.54
  • HUMA $1.43
  • Resistance Level
  • FEIM $33.72
  • HUMA $1.67
  • Average True Range (ATR)
  • FEIM 1.89
  • HUMA 0.15
  • MACD
  • FEIM 0.15
  • HUMA -0.01
  • Stochastic Oscillator
  • FEIM 82.03
  • HUMA 23.32

About FEIM Frequency Electronics Inc.

Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: